Stock Comparison
GILD vs JNJ
Gilead Sciences Inc and Johnson & Johnson side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$171.48B
$626.01B
P/E (TTM)
—
30.1
Forward P/E
15.8
22.3
Price/Sales
5.6
6.4
Price/Book
14.5
7.4
EV/EBITDA
104.8
19.3
Dividend Yield
1.74%
2.00%
Profitability
Net Margin
30.99%
21.83%
Operating Margin
38.61%
26.87%
Return on Equity
-20.70%
25.70%
Return on Assets
14.10%
8.60%
Growth (YoY)
Revenue Growth
10.20%
6.60%
Earnings Growth
54.80%
-0.90%
Price & Risk
Beta
0.3
0.2
52-Week High
$154.92
$267.34
52-Week Low
$109.22
$170.46
Analyst Target
$157.41
$272.50
Compare GILD and JNJ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.